Notify me when Hardman Johnston Global Advisors LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 71 | $2,098,691,831 | +$161,427,844 | -$156,958,075 | +$4,469,769 | ASML, IBN, HDB, MELI, HWM | 13F-HR | 23 Jan 2026, 10:41 |
| Q3 2025 | 72 | $2,035,132,730 | +$152,087,052 | -$358,841,836 | -$206,754,784 | MELI, IBN, HDB, ASML, NVDA | 13F-HR | 27 Oct 2025, 09:41 |
| Q2 2025 | 73 | $2,255,426,078 | +$77,364,929 | -$220,965,417 | -$143,600,488 | MELI, IBN, HDB, ASML, NVDA | 13F-HR | 21 Jul 2025, 12:05 |
| Q1 2025 | 73 | $2,093,216,638 | +$127,335,115 | -$399,451,684 | -$272,116,569 | IBN, HDB, MELI, TEAM, ASML | 13F-HR | 15 May 2025, 15:59 |
| Q4 2024 | 80 | $2,423,258,953 | +$186,228,580 | -$307,227,719 | -$120,999,139 | MELI, HDB, IBN, FTI, TEAM | 13F-HR | 04 Feb 2025, 10:51 |
| Q3 2024 | 77 | $2,551,154,856 | +$52,165,872 | -$198,048,108 | -$145,882,236 | MELI, FTI, HDB, IBN, HWM | 13F-HR | 30 Oct 2024, 16:26 |
| Q2 2024 | 74 | $2,586,568,397 | +$200,430,875 | -$546,344,353 | -$345,913,478 | MELI, FTI, HDB, IBN, ASML | 13F-HR | 14 Aug 2024, 08:37 |
| Q1 2024 | 76 | $2,898,617,616 | +$114,158,807 | -$569,552,534 | -$455,393,727 | MELI, FTI, IBN, TEAM, ASML | 13F-HR | 06 May 2024, 10:11 |
| Q4 2023 | 74 | $3,114,994,475 | +$238,620,447 | -$329,914,832 | -$91,294,385 | MELI, FTI, APTV, ALKS, TEAM | 13F-HR | 29 Jan 2024, 16:43 |
| Q3 2023 | 75 | $2,980,792,124 | +$245,549,921 | -$346,019,990 | -$100,470,069 | FTI, MELI, TEAM, BABA, ALKS | 13F-HR | 20 Oct 2023, 10:03 |
| Q2 2023 | 76 | $3,084,916,307 | +$101,318,621 | -$215,762,623 | -$114,444,002 | FTI, ALKS, MLCO, IBN, MELI | 13F-HR | 11 Aug 2023, 11:28 |
| Q1 2023 | 73 | $3,060,105,847 | +$506,830,572 | -$280,704,759 | +$226,125,813 | FTI, MLCO, ALKS, MELI, BABA | 13F-HR | 05 May 2023, 14:06 |
| Q4 2022 | 75 | $2,553,863,955 | +$283,173,265 | -$251,417,932 | +$31,755,333 | FTI, IBN, MLCO, APTV, ALKS | 13F-HR | 03 Feb 2023, 14:00 |
| Q3 2022 | 77 | $2,222,059,000 | +$199,526,071 | -$168,797,637 | +$30,728,434 | APTV, IBN, ALKS, MLCO, ASML | 13F-HR | 02 Nov 2022, 10:33 |
| Q2 2022 | 79 | $2,355,834,000 | +$92,127,647 | -$274,595,510 | -$182,467,863 | APTV, IBN, ALKS, TEAM, MLCO | 13F-HR | 02 Aug 2022, 16:36 |
| Q1 2022 | 78 | $3,114,464,000 | +$121,383,597 | -$236,372,335 | -$114,988,738 | IBN, APTV, TEAM, MLCO, ASML | 13F-HR | 12 May 2022, 16:28 |
| Q4 2021 | 77 | $3,708,143,000 | +$138,803,909 | -$272,072,430 | -$133,268,521 | APTV, TEAM, IBN, MLCO, SE | Restatement | 23 Mar 2022, 16:34 |
| Q3 2021 | 75 | $3,718,758,000 | +$226,179,602 | -$644,668,821 | -$418,489,219 | IBN, APTV, TEAM, MLCO, SE | 13F-HR | 12 Nov 2021, 12:50 |
| Q2 2021 | 77 | $4,130,899,000 | +$439,431,492 | -$117,449,462 | +$321,982,030 | TEAM, APTV, IBN, TSM, MLCO | 13F-HR | 09 Aug 2021, 15:10 |
| Q1 2021 | 77 | $3,512,858,000 | +$491,397,812 | -$532,309,149 | -$40,911,337 | MLCO, APTV, IBN, TEAM, TSM | 13F-HR | 12 May 2021, 11:03 |
| Q4 2020 | 79 | $3,446,773,000 | +$573,998,718 | -$127,348,171 | +$446,650,547 | TEAM, MLCO, BABA, APTV, IBN | 13F-HR | 10 Feb 2021, 21:44 |
| Q3 2020 | 76 | $2,671,542,000 | +$310,901,274 | -$138,343,743 | +$172,557,531 | BABA, TEAM, MLCO, ASML, IBN | 13F-HR | 13 Nov 2020, 21:01 |
| Q2 2020 | 75 | $2,269,705,000 | +$341,212,852 | -$127,318,874 | +$213,893,978 | BABA, MLCO, ASML, IBN, TEAM | 13F-HR | 23 Jul 2020, 16:51 |
| Q1 2020 | 73 | $1,718,938,000 | +$24,956,891 | -$233,158,657 | -$208,201,766 | BABA, ASML, IBN, MLCO, MSFT | 13F-HR | 04 May 2020, 16:41 |
| Q4 2019 | 69 | $2,478,439,000 | +$108,362,477 | -$152,732,713 | -$44,370,236 | BABA, IBN, MLCO, ASML, HDB | 13F-HR | 05 Feb 2020, 15:10 |
| Q3 2019 | 67 | $2,184,107,000 | +$107,060,409 | -$50,694,651 | +$56,365,758 | BABA, IBN, MLCO, ASML, QGEN | 13F-HR | 30 Oct 2019, 15:37 |
| Q2 2019 | 70 | $2,255,814,000 | +$36,982,251 | -$122,019,528 | -$85,037,277 | IBN, MLCO, BABA, QGEN, HDB | 13F-HR | 05 Aug 2019, 15:46 |
| Q1 2019 | 71 | $2,277,679,000 | +$138,116,923 | -$142,363,781 | -$4,246,858 | MLCO, IBN, BABA, QGEN, HDB | 13F-HR | 03 May 2019, 14:23 |
| Q4 2018 | 69 | $1,932,795,000 | +$189,703,574 | -$331,320,100 | -$141,616,526 | HDB, MLCO, BABA, QGEN, IBN | 13F-HR | 06 Feb 2019, 14:00 |
| Q3 2018 | 69 | $2,319,653,000 | +$88,960,566 | -$122,850,189 | -$33,889,623 | AVGO, BABA, MLCO, HDB, QGEN | 13F-HR | 17 Oct 2018, 17:50 |
| Q2 2018 | 71 | $2,366,165,000 | +$290,974,827 | -$356,287,495 | -$65,312,668 | HDB, AVGO, MLCO, BABA, QGEN | 13F-HR | 18 Jul 2018, 15:56 |
| Q1 2018 | 72 | $2,350,927,000 | +$198,889,853 | -$222,396,654 | -$23,506,801 | HDB, AVGO, MLCO, BABA, ASML | 13F-HR | 30 Apr 2018, 11:49 |
| Q4 2017 | 72 | $2,360,397,000 | +$279,461,443 | -$332,985,445 | -$53,524,002 | HDB, AVGO, BABA, MLCO, ASML | 13F-HR | 26 Jan 2018, 15:29 |
| Q3 2017 | 71 | $2,343,303,000 | +$39,826,811 | -$135,555,696 | -$95,728,885 | HDB, BABA, AVGO, AGN, ASML | 13F-HR | 30 Oct 2017, 16:13 |
| Q2 2017 | 76 | $2,317,091,000 | +$228,145,850 | -$267,762,818 | -$39,616,968 | HDB, AGN, AVGO, BABA, QGEN | Restatement | 14 Aug 2017, 10:20 |
| Q1 2017 | 76 | $2,225,433,000 | +$153,352,928 | -$229,991,643 | -$76,638,715 | AVGO, AGN, NXPI, HDB, MBBYF | 13F-HR | 09 May 2017, 20:36 |
| Q4 2016 | 77 | $2,049,924,000 | +$152,499,186 | -$233,931,536 | -$81,432,350 | AVGO, NXPI, AGN, HDB, QGEN | 13F-HR | 08 Feb 2017, 08:05 |
| Q3 2016 | 78 | $2,197,814,000 | +$113,362,107 | -$52,902,577 | +$60,459,530 | NXPI, AVGO, AGN, HDB, MBBYF | 13F-HR | 24 Oct 2016, 11:09 |
| Q2 2016 | 76 | $1,964,737,000 | +$305,000,232 | -$79,041,015 | +$225,959,217 | NXPI, AVGO, AGN, MBBYF, HDB | 13F-HR | 27 Jul 2016, 14:28 |
| Q1 2016 | 77 | $1,702,350,000 | +$305,771,323 | -$96,430,098 | +$209,341,225 | NXPI, BIDU, ASML, MBBYF, HDB | 13F-HR | 02 May 2016, 11:07 |
| Q4 2015 | 72 | $1,509,412,000 | +$137,917,991 | -$187,840,747 | -$49,922,756 | QGEN, NXPI, BIDU, HDB, ASML | 13F-HR | 09 Feb 2016, 16:30 |
| Q3 2015 | 73 | $1,504,481,000 | +$54,080,315 | -$71,012,707 | -$16,932,392 | QGEN, NXPI, HDB, ASML, BIDU | 13F-HR | 10 Nov 2015, 11:43 |
| Q2 2015 | 77 | $1,670,200,000 | +$73,673,482 | -$65,993,248 | +$7,680,234 | NXPI, QGEN, BIDU, ASML, ETN | 13F-HR | 11 Aug 2015, 08:12 |
| Q1 2015 | 78 | $1,655,536,000 | +$142,260,846 | -$410,220,318 | -$267,959,472 | NXPI, QGEN, BIDU, ASML, ETN | 13F-HR | 08 May 2015, 06:55 |
| Q4 2014 | 79 | $1,848,736,000 | +$233,002,133 | -$209,299,624 | +$23,702,509 | NXPI, BIDU, QGEN, ASML, DEO | 13F-HR | 04 Feb 2015, 12:57 |
| Q3 2014 | 80 | $1,809,924,000 | +$117,158,208 | -$120,969,709 | -$3,811,501 | NXPI, QGEN, ETN, ASML, DEO | 13F-HR | 12 Nov 2014, 09:29 |
| Q2 2014 | 81 | $1,872,914,000 | +$261,684,927 | -$100,996,803 | +$160,688,124 | NXPI, DEO, QGEN, ASML, ETN | 13F-HR | 12 Aug 2014, 10:10 |
| Q1 2014 | 80 | $1,711,371,000 | +$295,285,216 | -$78,180,470 | +$217,104,746 | DEO, ASML, ETN, NXPI, QGEN | 13F-HR | 15 May 2014, 13:02 |
| Q4 2013 | 78 | $1,523,430,000 | $0 | $0 | $0 | DEO, ASML, QGEN, MR, ADBE | 13F-HR | 10 Feb 2014, 09:55 |